-
-
No events on calendar for this bill.
-
Senator Sydney Batch(D)
Senator Michael Garrett(D)
Senator Natasha R. Marcus(D)
Senator Gale Adcock(D)
Senator Val Applewhite(D)
Senator Lisa Grafstein(D)
Senator Rachel Hunt(D)
Senator Paul A. Lowe, Jr.(D)
Senator Julie Mayfield(D)
Senator Mujtaba A. Mohammed(D)
Senator Natalie S. Murdock(D)
Senator Gladys A. Robinson(D)
Senator DeAndrea Salvador(D)
Senator Joyce Waddell(D)
-
Re-ref to Appropriations/Base Budget. If fav, re-ref to Rules and Operations of the SenateSenate2023-03-28Withdrawn From ComSenate2023-03-28Ref To Com On Rules and Operations of the SenateSenate2023-03-28Passed 1st ReadingSenate2023-03-28Filed
-
FiledNo fiscal notes available.Edition 1No fiscal notes available.
-
APPROPRIATIONS
BUDGETING
CONTROLLED SUBSTANCES
DHHS
FAMILY PLANNING
HEALTH SERVICES
PHARMACEUTICALS
PUBLIC
PUBLIC HEALTH
FAMILY ISSUES
-
-
No counties specifically cited.
-
-
-
S372: Community Health Center Grants for LARCs. Latest Version
Session: 2023 - 2024
AN ACT appropriating funds to the department of health and human services, division of public health, to provide grants to nonprofit community health centers for the purchase and distribution of long‑acting reversible contraceptives.
The General Assembly of North Carolina enacts:
SECTION 1. There is appropriated from the General Fund to the Department of Health and Human Services, Division of Public Health, the sum of five million dollars ($5,000,000) in nonrecurring funds for the 2023‑2024 fiscal year to be used to award grants on a competitive basis to nonprofit community health centers. Nonprofit community health centers selected to receive these grant funds shall use all such funds to purchase and make available long‑acting reversible contraceptives for underserved, uninsured, or medically indigent patients. As used in this section, the term long‑acting reversible contraceptives means a contraceptive drug or device that meets all of the following criteria:
(1) Is a method of birth control that provides effective contraception for an extended period of time without depending upon user action.
(2) Is designed as a temporary method of birth control that the user can elect to discontinue.
(3) Has been approved by the United States Food and Drug Administration for use as a contraceptive.
(4) Is obtained under a prescription written by a health care provider authorized to prescribe medications under the laws of this State.
SECTION 2. This act becomes effective July 1, 2023.